EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Should the Current Zero HLA ABDR-Mismatch Priority in Kidney Allocation System Continue?

Douglas Keith iD, Elizabeth Lessmann iD

Kidney360 · 2026-05 · 7 (5) · 1118-1127

DOI: 10.34067/kid.0000001132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 13.01.2026. Verfasst von Douglas Keith und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ascension Sacred Heart Kidney Transplant Program, Pensacola, Florida. Hauptthemen laut MEDLINE: Kidney Transplantation, Tissue and Organ Procurement, HLA Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ascension Sacred Heart Hospital in Pensacola.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Zero HLA ABDR mismatch priority in the Kidney Allocation System is highly biased against minority candidates. Zero HLA ABDR mismatch priority shunts 2.5% of O donors to nonidentical blood types disadvantaging O recipients. Zero HLA ABDR-mismatch priority recipients have substantially shorter dialysis exposure before transplant than nonpriority recipients.

Background

In the Kidney Allocation System (KAS), adult kidney candidates who are a zero HLA ABDR-mismatch with a potential donor are given priority in the match run over nonzero HLA ABDR-mismatch candidates. Furthermore, KAS allows for the shunting of kidneys to zero-mismatch candidates across compatible ABO blood types, potentially disadvantaging O candidates who have longer waiting times. This study was undertaken to determine who is receiving zero HLA ABDR-mismatch kidneys, the number of donors shunted to nonidentical ABO recipients, the effect on dialysis exposure before transplant, and the current patient and graft outcomes.

Methods

All adult deceased donor kidney recipients since the start of KAS on December 4, 2014, were included in the study. Multiorgan transplants with a kidney, 98%–100% calculated panel reactive antibodies (CPRAs), previous living donors, pediatric, medically urgent, and safety net transplants were excluded. Patients were considered a zero-mismatch allocation if they received a zero HLA ABDR-mismatch kidney and had an allocation CPRA

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationTissue and Organ ProcurementHLA AntigensHumansFemaleGraft SurvivalMaleMiddle AgedAdultABO Blood-Group SystemWaiting ListsHistocompatibility TestingTissue DonorsRetrospective StudiesRenal DialysisGraft Rejection

Stichwörter der Autor:innen

deceased donor organ transplantationtransplant outcomes

Substanzen

ABO Blood-Group SystemHLA Antigens

Autor:innen und Institutionen

  • Ascension Sacred Heart Kidney Transplant Program, Pensacola, Florida.

ORCID-Profile: Douglas Keith, Elizabeth Lessmann

Förderung

  • Ascension Sacred Heart Hospital in Pensacola

Zitieren

APA

Keith, D., & Lessmann, E. (2026). Should the Current Zero HLA ABDR-Mismatch Priority in Kidney Allocation System Continue?. Kidney360, 7(5), 1118-1127. https://doi.org/10.34067/kid.0000001132

Vancouver

Keith D, Lessmann E. Should the Current Zero HLA ABDR-Mismatch Priority in Kidney Allocation System Continue?. Kidney360. 2026;7(5):1118-1127. doi:10.34067/kid.0000001132

BibTeX
@article{Keith2026,
  author = {Keith, Douglas and Lessmann, Elizabeth},
  title = {Should the Current Zero HLA ABDR-Mismatch Priority in Kidney Allocation System Continue?},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {5},
  pages = {1118--1127},
  doi = {10.34067/kid.0000001132}
}
Kostenlos starten →